The document is an independent auditor's report that includes sections on the financial statements, management's responsibility, the auditor's responsibility, and their opinion. It also covers the company's performance in the current year, regulatory challenges and how they were overcome, new product research and development, corporate social responsibility efforts, global operations, and recent restructuring changes. Details on total debt and assets are also provided.

1. PREPARED BY
T HARI KUMAR(131449)

2. INDEPENDENT AUDITORS’
REPORT
• Report on the Financial Statements
• Management’s Responsibility for the
consolidated Financial Statements
• Auditors’ Responsibility
• Opinion
• Report on Other Legal and Regulatory
Requirements
For B S R & Co. LLP
Chartered Accountants
Registration No. 101248W
Akhil Bansal…

3. Performance of the company for the current accounting year.
REGULATORY CHALLENGES- Challenges faced by Ranbaxy &
how they overcome.
R & D - About their new product launch which drive their
profit margin.
CSR- As a part of core value it is to be there.
GLOBAL OPERATIONS- Total sales made by the company and
operations at their production house etc.
COMPANY’S RESTRUCTURING- Recent changes
made by the company.
Details of total debt to the company &
total asset owned by the company.

4. • Global industry structure and its development.
• Generics products.
• Ranbaxy’s performance country wise.
1. In terms of sales
2. In terms of income earned & expense incurred.
3. Their initiatives on
anti-Decease.

5. The company’s philosophy on code of corporate
governance
Board of directors
Board meetings
Committees of the board
Code of conduct
Certificate from CEO and CFO
Corporate governance voluntary guidelines, 2009